baber/WOPTO huggingface dataset:
Patent JP-H08190607-A (JP)
Title: Optical character reader
Inventor: SENOO KOJI
IPC: G06K9/20
Filed: 1995-01-05
Abstract: PURPOSE: To read object columns on forms in various format by automatically detecting the read object columns. CONSTITUTION: The optical character reader has a light emission source 3 which irradiates a form 2 with light, a light receiving element 4 which receives reflected light from the form 2 and transducers it into an electric signal, a binarization circuit 5 which sorts the electric signal according to a specific threshold value and convert it into a binarized signal, a storage circuit 6 which stores the binarized signal, and a recognition part 7 which recognizes the respective columns on the form 2 and the characters in the fields on the basis of the binarized signal.  The key word corresponding to the read object column is retrieved in the character strings in the respective columns on the form 2 to identify the column where the key word is present, columns in specific position relation with the column of the key word are taken as candidates for the read object column, and the column containing a character string having the attribute of the read object character string found among the candidates is identified as the read object column, thereby obtaining the character string as the read object character string.
Patent JP-S62157982-A (JP)
Title: Character reader
Inventor: SUDA MASATO
IPC: G06K9/36
Filed: 1986-01-06
Abstract: PURPOSE:To efficiently store information from plural observation systems in a frame image memory and to reduce a memory capacity by dividing a frame image memory and storing only the image information of character area from each observation system in each divided area. CONSTITUTION:An input multiplexer 7 selects only a character line area of 512X128 of the same position designated beforehand out of an input image of 512X512 picture elements from A/D conversion circuits 6a-6d according to a control signal from a control circuit 5, and distributes and stores in each of divided areas A1-A4 made by quadrisecting 512X512 frame image memory into 512X128 simultaneously. Consequently, among four images S1-S4, only necessary part is stored in a frame image memory 8. Character lines 2a-2d stored in the frame image memory 8 are selected successively by an output multiplexer 9 by controlling the signals of the control circuit 5 and outputted to a recognizing circuit 10. The recognizing circuit 10 makes detection, cutting out, discrimination etc. of character units from image information from each divided area A1-A4.
Patent JP-H03205291-A (JP)
Title: Controller for passenger conveyor
Inventor: SAKATA KAZUHIRO
IPC: B66B29/00
Filed: 1990-01-08
Abstract: PURPOSE:To secure safety by carrying out the operation corresponding to the utilization state by continuing operation by a maintained output device even if a microcomputer fails in the utilization by a common passenger, and immediately suspending operation by a cut-off output device at the time of the utilization by a passenger using a wheelchair. CONSTITUTION:When the defect of a microcomputer 81 is detected by a defect detecting device 201, operation is continued, keeping the output at the time point of trouble by a maintained output device 203 in case of the utilization for common passengers, and the trouble, of the falling-down one upon another, etc., are prevented. While, in case of the utilization by a passenger using a wheelchair, the output of the microcomputer 81 is cut off by a cut-off output device 204, and an immediate stop state is generated to prevent the collision of a spread step of the getting-on/off port. Further, a microcomputer 82 for restoration applies reset on the microcomputer 81 after trouble, and if an instruction for the utilization by common passengers is outputted, and the output state in trouble is inspected in the first execution of a program, and operation is continued, and the microcomputer 81 is returned to the initial state in the case of utilization by the passenger using a wheelchair, and restoration is enabled by the operation of an operator.
Patent JP-S61160995-A (JP)
Inventor: SHIMOJO TOKUHIDE
IPC: H05K3/46
Filed: 1985-01-08
Abstract: (57)【要約】本公報は電子出願前の出願データであるた め要約のデータは記録されません。
Patent JP-S58117890-A (JP)
Title: Highly corrosion resistant surface treated steel plate
Inventor: YOSHIHARA YOSHIHISA
IPC: C25D5/26
Filed: 1982-01-06
Abstract: PURPOSE:To obtain a titled steel plate having good corrosion resistance, paintability, and weldability by carrying out electroplating of metals (alloys) of Zn, Ni, etc. on the surface of a steel plate and forming a diffusion layer of said metals (alloys) by heating in the steel then carrying out plating of a Zn-Ni alloy on the surface of the steel plate. CONSTITUTION:Metallic plating of Zn, Ni, Sn, Cr or consisting essentially of these metals is carried out thinly on both front and rear surfaces of a steel plate. The plating in this case is carried out preferably at 0.5-20g/m<2> per one side. The steel plate after the plating is heated in a nonoxidative atmosphere to diffuse said plating metal thoroughly into the steel. Zn-Ni alloy plating is carried out on at least one surface of the steel plate formed with the diffused layer, whereby the intended surface treated steel plate having high corrosion resistance is obtained. The Zn-Ni alloy plating has a sacrificial effect of preventing corrosion when the content of Ni is 10-20wt% and is the range where the corrosion resistance is high.
Patent JP-S60209262-A (JP)
Title: Copper ion exchange medium and recovery of copper ion from copper ion-containing ammoniacial solution
Inventor: UORUTAA SHII BABUKOTSUKU
IPC: C22C3/00
Filed: 1985-01-07
Abstract: There is disclosed novel copper ion-exchange media and processes for the recovery of cupric ion from ammoniacal copper solutions and for the recovery of spent printed circuit board etchant. The novel ion-exchange media comprise hydrophobic nonporous polymer plasticized and swollen with a monomeric organic liquid copper ion-exchange agent such as beta-diketones or hydroxyoximes. A novel copper ion-complexing agent, 1-n-octylphenyl-p-1,3-butanedione, is also disclosed. The processes essentially comprise contacting the ammoniacal cupric ion-containing solution or spent etchant with the novel copper ion-exchange media to extract copper in cupric ion form. Copper can be recovered therefrom by conventional methods such as acid stripping and electrowinning.
Patent JP-S60148476-A (JP)
Inventor: OBATA JIYUNICHI
IPC: B65D81/02
Filed: 1984-01-09
Abstract: (57)【要約】本公報は電子出願前の出願データであるた め要約のデータは記録されません。
Patent JP-H01177511-A (JP)
Title: Scanning optical device
Inventor: ANDO TOSHINORI
IPC: H04N1/23
Filed: 1988-01-06
Abstract: PURPOSE:To adjust a spot on the surface to be scanned to a desired size even in case a size of said spot has been varied due to an environmental fluctuation by detecting an image forming state of a laser light on the surface to be scanned and adjusting an image forming position of the laser light, based on an obtained signal. CONSTITUTION:A laser luminous flux L is brought to image formation on a CCD 8 provided on a position being equivalent optically to a photosensitive drum 9 and its spot diameter is detected. In this case, the smaller the spot diameter in the scanning direction becomes, the larger the contrast V becomes, therefore, in case a value which has been set in advance and the calculated V are compared and the V has become smaller than a prescribed value, a driving signal is sent out to a focus adjusting means 4 from a control part 10 and a collimator lens system 3 is moved by a prescribed quantity in the direction as indicated with an arrow A. In such a way, it can be prevented that the laser spot diameter is enlarged due to an environmental fluctuation such as a temperature, etc., a spot of a desired size can always be obtained, and an image of high density and high quality can be formed.
Patent JP-H01178183-A (JP)
Title: Tape cassette
Inventor: YOSHII TETSUJI
IPC: G11B23/087
Filed: 1988-01-06
Abstract: PURPOSE:To suppress a tensile force being added on tape tension when a tape comes to an end from being increased by providing a buffer arm engaged with the tape whose end part is clamped on a hub and supported elastically. CONSTITUTION:The buffer arm 7 is formed integrally with a tape clamper 9. Therefore, when the tensile force is increased by the arrival of the end of the tape, the hub at a tape supply side deforms the buffer arm 7 against its elasticity, and sudden stoppage can be evaded. Also, the free end of the buffer arm 7 is set so as to be positioned at the front of rotation at the time of supplying the tape observing from its supporting part side. In such a way, it is possible to suppress the increase of the tensile force being applied on the tape when the tape comes to the end.
Patent JP-H02276846-A (JP)
Title: Electrically conductive thermoplastic resin composition
Inventor: YOSHIMURA YASUO
IPC: C08K7/04
Filed: 1990-01-09
Abstract: PURPOSE:To obtain the subject composition suitable for electromagnetic field shield housing, having excellent surface appearance and preventing characteristics of electromagnetic wave fault by blending a styrene-based resin composition with a resin component having bonding function to stainless steel and stainless steel fibers. CONSTITUTION:A styrene-based resin (e.g. high-impact polystyrene or acrylonitrile-butadiene-styrene copolymer) composition containing 2-50mum diameter is blended with 1-50wt.%, preferably 1-30wt.% resin component (e.g. thermoplastic polyester resin or polypropylene maleic anhydride copolymer) having bonding function to stainless steel and stainless steel fibers.
Patent OA-08768-A (OA)
Inventor: JUDITH FEINBERG
IPC: A61P37/00
Filed: 1987-10-21
Abstract: Patients infected with the virus which causes AIDS, HTLV-III, are administered high doses of recombinant alpha interferon which are sufficient to make the patients aviremic. The high doses can range from about 5 to 75 million International units of human recombinant interferon alfa-2, preferably alfa-2b, per day by single injection. The patients can be maintained in an aviremic state by maintaining a dosage regimen of from about 10 to 35 million International units, in single doses, from 3 to 7 days per week.
Patent OA-09365-A (OA)
Inventor: ARMAND COHEN
IPC: C07D209/08
Filed: 1991-06-14
Abstract: New process for industrial preparation of 4-chloro-3-sulphamoyl-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)benzamide from monochloramine and 2,3-dihydro-2-methyl-1H-indole.
Patent OA-09839-A (OA)
Inventor: CEVALLOS AGUSTIN
IPC: A23L27/16
Filed: 1993-09-07
Abstract: The invention relates to a process for preparing a flavouring agent based on an aromatic herb, lovage, a sugar and an onion extract, which can be incorporated into various dishes.
Patent PH-18070-A (PH)
Title: Alkanolamine derivatives and pharmaceutical compositions containing them
Inventor: BARLOW JEFFREY JOHN
IPC: C07D409/12
Filed: 1982-01-29
Abstract: Novel alkanolamine derivatives of the formula: ArOCH2.CHOH.CH2NHA1NHCO  +TR <IMAGE>  wherein Ar is phenyl or naphthyl which is unsubstituted or which bears one or two substituents selected from halogen, trifluoromethyl, hydroxy, amino, nitro, carbamoyl, carbamoylmethyl and cyano, and alkyl, alkenyl, alkoxy, alkenyloxy, alkylthio, alkanoyl and alkanoylamino each of up to 6 carbon atoms, or Ar is 4-indolyl, 4-benzo[b]thienyl, 5-benzo[1,4]dioxanyl, 4- or 5-indanyl, 5- or 6- 1,2,3,4-tetrahydronaphthyl), 2,3-dihydroxy-1,2,3,4-tetrahydronaphth-5-yl or 4- morpholino-1,2,5-thiadiazol-3-yl; wherein R is halogen; wherein A1 is alkylene of 2 to 6 carbon atoms; and wherein A2 is alkylene of 1 to 7 carbon atoms which in unsubstituted or bears a phenyl, hydroxy or carbamoyl substituent, or A2 is cycloalkylene of 3 to 6 carbon atoms; or acid-addition salts thereof. The compounds possess either  beta -adrenergic blocking activity or diuretic activity or both such activities and may be used in the treatment of heart disease or hypertension. Also disclosed are processes for the manufacture of the compounds and pharmaceutical compositions containing them.
Patent PH-19643-A (PH)
Title: Detergent compositions
Inventor: GAVIN MALCOLM
IPC: C11D3/066
Filed: 1983-11-14
Abstract: In a foaming liquid detergent composition suitable inter alia for hand dishwashing and including in its detergent-active system a dialkyl sulphosuccinate, performance is enhanced and physical characteristics (stability, viscosity, hydrotrope requirement) are improved by the inclusion of a fatty acid dialkanolamide such as lauric diethanolamide.
Patent PH-22957-A (PH)
Title: Monoclonal antibodies with specificity for crosslinked fibrin derivatives and assay for said derivatives
Inventor: BUNDESEN PETER GREGORY
IPC: G01N33/68
Filed: 1984-03-13
Abstract: The invention relates to a method of preparation of monoclonal antibody derived from a crosslinked fibrin derivative including the steps of:(i) obtaining a crosslinked fibrin derivative or extract containing same; and(ii) forming antibody to said derivative or extract by cloning antibody producing cells from an animal having been administered thereto said derivative or extract.There is also provided a screening assay for use in the abovementioned method which includes the steps of:(A) coating a surface with antigen selected from(i) crosslinked fibrin derivative;(ii) extract containing said derivative; or(iii) fibrinogen degradation product.(B) contacting said antigen with monoclonal antibody derived from crosslinked fibrin derivative; and(C) subjecting the complex formed in step (A) to a signal amplification step.There is also disclosed an assay procedure for detection of the presence of a crosslinked fibrin derivative in an animal body fluid including the steps of:(i) contacting monoclonal antibody prepared from a crosslinked fibrin derivative with a fluid sample suspected of containing an antigen derived from a crosslinked fibrin derivative or comprising a crosslinked fibrin derivative perse; and(ii) subjecting the complex formed in step (1) to a signal amplification step.
Patent PH-30830-A (PH)
Title: Compounds containing a fused bicyclic ring and process therefor.
Inventor: ROBE JEFFREY A
IPC: C07D/
Filed: 1994-06-14
Abstract: Compounds of the formula <CHEM> wherein X is O or S-(O)t; n is one or two; m is zero or one; Y is CH2, O, or S-(O)t provided that Y is O or S-(O)t only when m is one; and A is <CHEM>  are dual inhibitors of NEP and ACE. Compounds wherein A is <CHEM> are selective ACE inhibitors. Also disclosed are methods of preparation and intermediates.
Patent TR-26569-A (TR)
IPC: G11B27/10
Filed: 1991-06-21
Abstract: The disk recording appts. sequentially inputs data to a memory (14) at one transfer rate. This data is subsequently read out at a second, higher transfer rate and recorded to disk (2). The amounts of data read from the memory are set so that there is a writing space in memory. During playback, the recorded data are reproduced at a rate, higher than the rate for outputting the data, and stored in a memory (22). Again the amount of data read always maintains a minimum amount of data in the memory (22).
Patent UY-32023-A (UY)
Title: Reactor heterogéneo para catalizador de hidrógeno
Inventor: MILLS RANDELL L
IPC: B01J3/00
Filed: 2009-07-30
Abstract: Se proporcionan fuentes de energía y reactores del hidruro comprendiendo una célula de reacción para la catálisis del hidrógeno atómico para la formación de hidrinos, fuente de hidrógeno atómico y catalizador de hidrógeno o fuente de catalizador de hidrógeno. La reacción de catálisis puede activarse y programarse por una o mas reacciones químicas diferentes, tales como (i) exotérmicas, (ii) acopladas, (iii) radicales libres, (iv) oxidación-reducción, (v) intercambio, (vi) reacciones de los hidrinos asistidos por afinadores de vacío, soportes o matrices. También proporcionan plantas químicas y energéticas pudiendo ser operadas de forma continua, utilizando electrolisis o reacciones de regeneración térmica contenidas en sincronía con la producción energética y la producción química con hidrógeno de baja energía
Patent UY-32790-A (UY)
Title: Compuesto de ftalazinona
Inventor: NEIL HAWKINS
IPC: A61K31/445
Filed: 2010-07-15
Abstract: 4-(4-fluoro-3-(4-metoxipiperidin-1-carbonil)bencil)ftalazin-1(2H)-ona como la forma cristalina C.
Patent UY-33562-A (UY)
Title: Agonistas de receptores de bradicinina y su utilización para el tratamiento de la hipertensión ocular y el glaucoma
Inventor: HWANG-HSING CHEN
IPC: A61K31/4184
Filed: 2011-08-17
Abstract: La invención da a conocer composiciones y métodos para tratar y/o prevenir trastornos oculares asociados con la presión intraocular elevada. En particular, los compuestos son agonistas de la bradicinina.
Patent UY-35073-A (UY)
Title: Derivados de pirrolidinona como moduladores de GPR119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados.
Inventor: SCHWINK DR LOTHAR
IPC: A61K31/341
Filed: 2013-10-09
Abstract: La presente invención se refiere a derivados de pirrolidinona. Los derivados de pirrolidina son moduladores de GPR119 y son útiles para la prevención y/o el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados. La invención se refiere además al uso de derivados de pirrolidinona como ingredientes activos en sustancias farmacéuticas, y composiciones farmacéuticas que los contienen.
Patent UY-36072-A (UY)
Title: Nuevos compuestos macrocíclicos
Inventor: WASNAIRE DR PIERRE
IPC: C07D498/18
Filed: 2015-04-09
Abstract: Nuevos compuestos macrocíclicos de la fórmula general (I) como se los describe y se los define en la memoria descriptiva. Métodos para prepararlos. Su uso en el tratamiento y/o la profilaxis de diversos trastornos,particularmente de los trastornos hiperproliferativos, de las enfermedades infecciosas inducidas por virus y/o de las enfermedades cardiovasculares. Compuestos intermedios útiles para preparar los compuestos de la fórmula general (I).
Patent UY-36207-A (UY)
Title: Inhibidores de la syk
Inventor: BLOMGREN PETER A
IPC: C07D487/00
Filed: 2015-07-08
Abstract: La presente divulgación se relaciona con compuestos que son inhibidores de Syk y con su uso en el tratamiento de diferentes estados de enfermedad, incluyendo cáncer y condiciones inflamatorias. En realizaciones particulares, la estructura del compuestos está dada por la Formula I:donde R1, R2, R3, y R4 son como se describe aquí. La presente descripción proporciona además composiciones farmacéuticas que incluyen un compuesto de Fórmula I, o sales farmacéuticamente aceptables de los mismos, y métodos de uso de estos compuestos y composiciones para tratar afecciones mediadas por Syk. En ciertas realizaciones, también se describen métodos para el tratamiento de un cáncer en un sujeto (por ejemplo, un humano) que requiera de los mismos, que comprende administrar al sujeto una cantidad terapéuticamente efectiva de un compuesto de Fórmula I, o una sal farmacéuticamente aceptable del mismo, en combinación con un alcaloide de la vinca, o una sal farmacéuticamente aceptable del mismo.
Patent UY-38321-A (UY)
Title: Proceso de obtención de un sustituto dérmico a partir de membrana amniótica descelularizada y su uso como agente de regeneración
Inventor: EDUARDO ALVARO GALUE
IPC: C12N5/073
Filed: 2019-07-30
Abstract: La presente invención provee un proceso de obtención de un sustituto dérmico funcional a partir de membrana amniótica descelularizada proveniente de placenta en combinación con queratinocitos de mamífero y su uso como agente de regeneración tisular de piel, el cual consiste en un proceso para la generación de un injerto de piel artificial en laboratorio utilizando técnicas especializadas en biotecnología como es el cultivo de células de mamífero, preferentemente humanas, en el cual se cultivan en condiciones asépticas los queratinocitos que forman parte de la capa epidérmica de la piel.
Patent YU-53701-A (YU)
Title: Full body atomised bath and method for providing a full body atomised bath
Inventor: BUSSELMANN MANFRED
IPC: B05B1/18
Filed: 1999-12-16
Abstract: The invention relates to a method for providing a full body atomised bath and to a full body atomised bath device (2), comprising a bathing cubicle (1) for accommodating at least one person and the atomised liquid, and a liquid atomiser (20) for providing the atomised liquid. Said liquid atomiser has a high pressure chamber (21) in which the liquid is compressed by being subjected to high pressure and a nozzle (27, 28) for explosively ejecting the highly pressurised compressed liquid which is consequently atomised into small particles. The particles are positively charged and their photon emission is increased.
Patent YU-61089-A (YU)
Title: Vibration insulation for assembly parts connections of manual tools
Inventor: BOBRY M W
IPC: B25D17/24
Filed: 1989-03-24
Abstract: The vibro-isolation of connections of structural units of hand tools consists of a vibro-isolator with a constant reaction force. On the side of a body (3) of a compressed-air engine an upper (9) and a lower (10) elastic guide is provided as a first stage of vibro-isolation in directions (x, y) perpendicular to the axis of symmetry of the tool. In the main direction (z) parallel to the axis of symmetry of the tool vibro-isolation is ensured by an elastic system consisting of a vibro-isolator (1) with a constant reaction force connected to the body (3) of the compressed-air engine through a spring washer (2). On the side of a grip (14) a vibro-isolator (1) with a constant reaction force is mounted through a spring washer (6) and sleve (7) acting as a second stage of vibro-isolation of the grip (14). Moreover, the second stage of vibro-isolation for the left hand of an operator is the grip itself in the form of a spring sleeve (13) screwed onto the end-portion of the body-housing (8). The vibro-isolation of an air-supply system includes an intermediate sleeve (17) and a silent-block connection of a supply unit (15) with the grip (14).
Patent YU-87990-A (YU)
Inventor: HUBERT BARTH
IPC: C07D491/056
Filed: 1990-05-04
Abstract: The invention relates to novel bis(1H-indol-3-yl)maleimide derivatives, a process for their preparation, pharmaceuticals containing these compounds and their use for the treatment of cardiac and vascular diseases such as thromboses, arteriosclerosis, hypertension, inflammatory processes, allergies, cancer and certain types of degenerative damage of the central nervous system and also disorders of the immune system and viral diseases.
Patent AT-A120594-A (AT)
IPC: C02F3/30
Filed: 1994-06-17
Abstract: In a biological sewage treatment plant having at least one settling tank 2, an activation tank 10 and a secondary clarification tank 22, a first chamber 4 for the anaerobic degradation is disposed immediately downstream of the first settling tank 2 connected to the feed 1. The chamber 4 is connected to a further settling tank 5. A second chamber 7 for the anaerobic degradation is connected to the first settling tank 2, at the end of which second chamber is provided a suction tube 8 with air introduction devices 11 for introducing the liquid to be clarified into the activation tank 10. An overflow 13 of the activation tank 10 is connected to the secondary clarification tank 22. The wastewater, subsequently to a mechanical cleanup in the first settling tank 2 is conducted at first at least in part through a first anaerobic zone 4 into a second settling tank 5 and back again via the first anaerobic zone 4 into the first settling tank 2 and then fed to a second anaerobic zone 7 after which it is subjected to an aerobic degradation. <IMAGE>